Small Molecules, Monoclonal Antibody
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
33
NCT06976892
Investigating Idetrexed and Olaparib in Patients With Ovarian Cancer
Phase: Phase 1
Role: Collaborator
Start: Aug 31, 2025
Completion: Dec 31, 2029
Loading map...